Agent Orange Exposure Does Not Modify the Rate of Developing Certain Service-Connected Cancers in U.S. Veterans with Monoclonal Gammopathy of Undetermined Significance
Military Medicine · 13.11.2026
DOI: 10.1093/milmed/usag515 ↗Kurz gefasst
Fachartikel in der Zeitschrift Military Medicine, online erschienen am 13.11.2026. Verfasst von Helen Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of Hematology-Oncology, Department of Medicine, Tibor Rubin VA Medical Center, Long Beach, CA 90822, United States. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Veteran Affairs Career Development, Lymphoma Research Foundation Lymphoma Scientific Research Mentoring, University of California Irvine/Veteran Affairs Informatics Pilot.
Abstract (Originalsprache)
Introduction
Agent Orange (AO) exposure has been associated with increased risk of monoclonal gammopathy of undetermined significance (MGUS), the precursor of multiple myeloma, as well as certain hematologic and solid malignancies in U.S. military personnel. However, the association between AO exposure and subsequent cancers among Veterans with a prior diagnosis of MGUS has not been examined. Materials and Methods The source of subjects were US Veterans diagnosed with MGUS in the national Veteran Health Administration system between 1988 and 2024. A retrospective cohort analysis using multivariable Cox proportional hazards models was employed to evaluate the association between AO exposure and developing certain service-connected cancers after MGUS diagnosis, adjusting for age at MGUS diagnosis, sex, military branch, and tobacco use. Results were reported as adjusted hazard ratios (aHR) with 95% confidence intervals (CI).
Results
Subsequent cancers occurred in 850 out of 3,246 patients (26%) during the study period with a median follow-up of 5.2 years. AO exposure was not associated with a higher rate of cancers overall (aHR, 0.95; 95% CI, 0.79-1.15; P = .60), or specific service-connected cancers, such as plasma cell neoplasms (aHR, 1.07; 95% CI, 0.78-1.47; P = .69), respiratory cancer (aHR, 0.86; 95% CI, 0.55-1.34; P = .50), prostate cancer (aHR, 1.05; 95% CI, 0.69-1.62; P = .81), and lymphoma (aHR, 1.10; 95% CI, 0.63-1.93; P = .73). Bladder cancer and soft tissue sarcoma had insufficient counts for stable model-based estimation and are reported descriptively only.
Conclusions
Prior AO exposure was not associated with an increased rate of subsequent service-connected cancers in Veterans diagnosed with MGUS over a median follow-up of 5.2 years. These findings underscore the need for improved exposure data collection within military personnel cohorts to facilitate discovery of military-specific cancer risk factors.
Autor:innen und Institutionen
- Section of Hematology-Oncology, Department of Medicine, Tibor Rubin VA Medical Center, Long Beach, CA 90822, United States.
- Division of Hematology-Oncology, Department of Medicine, School of Medicine, University of California Irvine, Irvine, CA 92697, United States.
- School of Technology for Public Health, Arizona State University, Phoenix, AZ 85004, United States.
- Department of Epidemiology and Biostatistics, UCI Program in Public Health, Susan and Henry Samueli College of Health Sciences, University of California Irvine, Irvine, CA 92617, United States.
- Department of Epidemiology, University of Washington, Seattle, WA 98195, United States.
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange, CA 92868, United States.
ORCID-Profile: Helen Ma, Wendy Cozen
Förderung
- Veteran Affairs Career Development
- Lymphoma Research Foundation Lymphoma Scientific Research Mentoring
- University of California Irvine/Veteran Affairs Informatics Pilot
Zitieren
APA
Ma, H., He, L., Wan, J. Y., Cozen, W., & Gupta, P. (2026). Agent Orange Exposure Does Not Modify the Rate of Developing Certain Service-Connected Cancers in U.S. Veterans with Monoclonal Gammopathy of Undetermined Significance. Military Medicine. https://doi.org/10.1093/milmed/usag515
Vancouver
Ma H, He L, Wan JY, Cozen W, Gupta P. Agent Orange Exposure Does Not Modify the Rate of Developing Certain Service-Connected Cancers in U.S. Veterans with Monoclonal Gammopathy of Undetermined Significance. Military Medicine. 2026. doi:10.1093/milmed/usag515
BibTeX
@article{Ma2026,
author = {Ma, Helen and He, Lu and Wan, Jia Y and Cozen, Wendy and Gupta, Pankaj},
title = {Agent Orange Exposure Does Not Modify the Rate of Developing Certain Service-Connected Cancers in U.S. Veterans with Monoclonal Gammopathy of Undetermined Significance},
journal = {Military Medicine},
year = {2026},
doi = {10.1093/milmed/usag515}
}
EUVIMED